Skip to main content

Japan's NGK Licenses OGT's Oligo IP to Develop, Sell Microarrays

NEW YORK (GenomeWeb News) – Japan’s NGK Insulators has licensed from Oxford Gene Technology patents for oligonucleotide microarrays in order to manufacture its own arrays, OGT said today.
 
The Japanese company will make the arrays using a technology called Geneshot, which uses piezoelectric ceramic microactuators. NGK can sell these OEM and NGK-branded microarrays in Japan.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.          

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.